Big Pharma > Is the FDA complicit in Big Pharma's exorbitant drug pricing?

 

China’s new cancer drug Toripalimab is approved in the US

but will cost 30 times more

• 
  
• In China, a single-dose vial costs US$280 but in the US it will have a wholesale price of US$8,892
• 
  
• Following the approval by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution this month
• 
  

Victoria Bela

Published: 3:04pm, 29 Nov, 2023

South China Morning Post

Does the FDA not have the power to refuse approval

for a new drug that is grossly overpriced?